Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-23-043514

President & CEO acquired 89,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pons Jaume President & CEO 2023-07-25 Grant or award +89,000 625,538 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Pons Jaume President & CEO 2023-07-25 Grant or award · Employee Stock Option (right to buy) +282,000 282,000 D: show line 2 in the form
Loading xslF345X05/doc4.xml…